OAM
ACOR

Oxford Asset Management’s Acorda Therapeutics ACOR Stock Holding History

Oxford Asset Management’s Portfolio ACOR Stock Details ACOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,952
Closed -$672K – 2184
2019
Q3 		$672K Sell
1,952
-743
-28% -$404K 0.02% 1133
2019
Q2 		$2.48M Buy
2,695
+2,494
+1,241% +$3.06M 0.05% 551
2019
Q1 		$320K Buy
+201
New +$362K 0.01% 1397
2018
Q4 		– Sell
-331
Closed -$779K – 2194
2018
Q3 		$779K Sell
331
-330
-50% -$1.02M 0.02% 1122
2018
Q2 		$2.27M Buy
661
+262
+66% +$802K 0.04% 595
2018
Q1 		$1.13M Sell
399
-569
-59% -$1.7M 0.02% 883
2017
Q4 		$2.62M Buy
968
+257
+36% +$731K 0.06% 443
2017
Q3 		$2.02M Buy
+711
New +$1.87M 0.04% 618
2017
Q2 		– Sell
-588
Closed -$1.48M – 1750
2017
Q1 		$1.48M Sell
588
-1,509
-72% -$4.34M 0.04% 642
2016
Q4 		$4.73M Sell
2,097
-1,111
-35% -$2.64M 0.17% 119
2016
Q3 		$8.04M Buy
3,208
+1,786
+126% +$5.33M 0.25% 95
2016
Q2 		$4.35M Buy
1,422
+1,189
+510% +$3.87M 0.14% 174
2016
Q1 		$741K Sell
233
-56
-19% -$232K 0.02% 540
2015
Q4 		$1.49M Sell
289
-864
-75% -$3.78M 0.04% 451
2015
Q3 		$3.67M Buy
1,153
+127
+12% +$493K 0.12% 183
2015
Q2 		$4.1M Sell
1,026
-1,150
-53% -$4.44M 0.11% 210
2015
Q1 		$8.69M Buy
2,176
+1,392
+178% +$6.38M 0.22% 99
2014
Q4 		$3.82M Sell
784
-33
-4% -$142K 0.08% 252
2014
Q3 		$3.32M Buy
+817
New +$3.06M 0.08% 262

Other funds holding ACOR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Oxford Asset Management's ACOR Position: Q4 2019 in Review

Oxford Asset Management sold out of Acorda Therapeutics (ACOR) in Q4 2019, closing a stake of 1,952 shares — an estimated $672K sold.

Oxford Asset Management first reported a position in ACOR in Q3 2014 and held it in 19 quarters. The position peaked at $8.69M in Q1 2015. 121 funds tracked by Wall St. Rank hold ACOR as of Q4 2019.

  • Oxford Asset Management reported no remaining Acorda Therapeutics position as of Q4 2019 after selling out during the quarter.
  • Oxford Asset Management sold 1,952 Acorda Therapeutics shares in Q4 2019, an estimated $672K.
  • Oxford Asset Management first reported a position in Acorda Therapeutics in Q3 2014 and held it in 19 quarters.
  • Oxford Asset Management's Acorda Therapeutics position peaked at $8.69M in Q1 2015.
  • 121 funds tracked by Wall St. Rank held Acorda Therapeutics as of Q4 2019.

Based on Oxford Asset Management's 13F filing for Q4 2019, filed 13 Feb 2020.